(Q43572389)

English

Expression status of wild-type HSP110 correlates with HSP110 T17 deletion size and patient prognosis in microsatellite-unstable colorectal cancer

scientific article published on 13 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Expression status of wild-type HSP110 correlates with HSP110 T17 deletion size and patient prognosis in microsatellite-unstable colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

colorectal cancer

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Gyeong Hoon Kang

object named as

Gyeong Hoon Kang

7

0 references

author name string

Jung Ho Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kyung-Ju Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Ye-Young Rhee

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sohee Oh

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Nam-Yun Cho

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

13 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

443-453

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.160

0 references

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Clinical relevance of microsatellite instability in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Systematic review of microsatellite instability and colorectal cancer prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Microsatellite instability in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Microsatellite instability and colorectal cancer prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Colorectal cancer molecular biology moves into clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Brush border myosin Ia has tumor suppressor activity in the intestine.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Heat shock proteins as danger signals for cancer detection

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Heat-shock proteins in infection-mediated inflammation-induced tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Targeting heat shock proteins in cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Heat shock proteins: stress proteins with Janus-like properties in cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Guidelines for the nomenclature of the human heat shock proteins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Significant overexpression of Hsp110 gene during colorectal cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

21 January 2018

Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

7 January 2021

based on heuristic

inferred from DOI database lookup

Poor Survival Associated with theBRAFV600E Mutation in Microsatellite-Stable Colon Cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta2-microglobulin mutations in microsatellite unstable colorectal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

7 January 2021

based on heuristic

inferred from DOI database lookup

Heat-shock proteins in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.160

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2013.160

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43572389&oldid=2101206102"